http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SK-682001-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28753ec2306a503b46954f354aaa946a |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375 |
| filingDate | 2001-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7a6dec9cfa02235b9aec7094d555eaf |
| publicationDate | 2002-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SK-682001-A3 |
| titleOfInvention | A pharmaceutical composition comprising ascorbate and at least one fibrinolysis inhibitor |
| abstract | Compositions for the prevention and treatment of diseases or pathologiesnconditions associated with degradation of extracellular matter,nespecially degenerative diseases such as arteriosclerosis,ncancer, infection, and more. inflammatory disease, consistsnmainly of lysine, proline, ascorbate and their derivatives and syntheticnanalogs and vitamins, provitamins and trace mineralsnelements. |
| priorityDate | 2001-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 75.